Impact of KRAS mutations and subtypes on efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) Meeting Abstract


Authors: Mazieres, J.; Tomasini, P.; Lusque, A.; Boucekine, M.; Gautschi, O.; Cortot, A. B.; Couraud, S.; Thai, A.; Ng, T.; Greillier, L.; Veillon, R.; Neal, J. W.; Popat, S.; Gounant, V.; Mhanna, L.; Drilon, A.; Baron, J. M.; Barlesi, F.
Abstract Title: Impact of KRAS mutations and subtypes on efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC)
Meeting Title: ESMO Virtual Congress 2020
Journal Title: Annals of Oncology
Volume: 31
Issue: Suppl. 4
Meeting Dates: 2020 Sep 19-21/Oct 16-18
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2020-09-01
Start Page: S826
End Page: S827
Language: English
ACCESSION: WOS:000573469101565
DOI: 10.1016/j.annonc.2020.08.1593
PROVIDER: wos
Notes: Meeting Abstract: 1279P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon